Why the study?
Does a research high-sensitivity cardiac troponin I (hs-cTnI) assay predict short- and long-term risk of death or MI in patients presenting to the emergency department with suspected ACS?
Population
383 subjects presenting to the emergency department with symptoms suggestive of acute coronary syndrome (ACS)
Comparison
Risk stratification using a research… vs Comparison across hs-cTnI concentration tiers
Design
Cohort
Follow-up
up to 10 years
Authors
Loading...
hs-cTnI thresholds may aid risk stratification in ED suspected ACS; leaves open whether assay use improves outcomes or warrants practice change.
Does a research high-sensitivity cardiac troponin I (hs-cTnI) assay predict short- and long-term risk of death or MI in patients presenting to the emergency department with suspected ACS?
A research high-sensitivity cardiac troponin I assay is useful for short- and long-term risk stratification for death or MI in patients presenting to the emergency department with suspected ACS.
Kavsak et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: